Table 1.

Patients’ demographic characteristics.

	Median	Range
Age	68	38–85
	n	(%)
Sex
Male	16	(57.2)
Female	12	(42.9)
UICC 7th edition TNM Staging
Stage I	9	(32.1)
Stage II	7	(25.0)
Stage III	4	(14.3)
Stage IV	8	(28.6)
Treatment
Surgery	28	(100)
Chemotherapy *	28	(100)
Radiotherapy	28	(100)

*: Cisplatin/Oxaliplatin + 5-FU + anthracycline.